Role of immunomarkers in the clinicopathological analysis of unicystic ameloblastoma

Disease Markers

Volumn 35, Issue 5, 2013, Pages 481-488

  Sah, Parul ^a   Menon, Aparna ^a   Kamath, Asha ^b   Chandrashekar, Chetana ^a   Carnelio, Sunitha ^a   Radhakrishnan, Raghu ^a  

^a MANIPAL COLLEGE OF DENTAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; PROTEINASE; TUMOR MARKER;

ADOLESCENT; ADULT; AMELOBLASTOMA; ANGIOGENESIS; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MANDIBLE RESECTION; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR INVASION; UNICYSTIC AMELOBLASTOMA; YOUNG ADULT;

ADOLESCENT; ADULT; AMELOBLASTOMA; ANTIGENS, CD34; FEMALE; HUMANS; JAW NEOPLASMS; KI-67 ANTIGEN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84890386608     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/517834     Document Type: Article

References (30)

1. D. G. Gardner, K. Heikinheimo, M. Shear, H. P. Philipsen, and H. Coleman, "Ameloblastomas," in World Health Organization Classification of Tumors. Pathology and Genetics.Head and Neck Tumours, L. Barnes, J.W. Eveson, P. Reichart, and D. Sidransky, Eds., pp. 296-300, IARC Press, Lyon, France, 2005.
2. H. P. Philipsen and P. A. Reichart, "Unicystic ameloblastoma: a review of 193 cases from the literature," Oral Oncology, vol. 34, no. 5, pp. 317-325, 1998.
3. L. Robinson and M. G. Martinez, "Unicystic ameloblastoma: a prognostically distinct entity," Cancer, vol. 40, no. 5, pp. 2278-2285, 1977.
4. T. J. Li, Y. T.Wu, S. F. Yu, and G. Y. Yu, "Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients," The American Journal of Surgical Pathology, vol. 24, no. 10, pp. 1385-1392, 2000.
5. R. A. Vickers and R. J. Gorlin, "Ameloblastoma: delineation of early histopathologic features of neoplasia," Cancer, vol. 26, no. 3, pp. 699-710, 1970.
6. Z. Chaudhary, V. Sangwan, U. S. Pal, and P. Sharma, "Unicystic ameloblastoma: a diagnostic dilemma," National Journal of Maxillofacial Surgery, vol. 2, no. 1, pp. 89-92, 2011.
7. G. L. Ackermann, M. Altini, and M. Shear, "The unicystic ameloblastoma: a clinicopathological study of 57 cases," Journal of Oral Pathology, vol. 17, no. 9-10, pp. 541-546, 1988.
8. R. S. Ramesh, S. Manjunath, T. H. Ustad, S. Pais, and K. Shivakumar, "Unicystic ameloblastoma of the mandible-an unusual case report and review of literature," Head and Neck Oncology, vol. 2, article 1, 2010.
9. A.Abdel-Aziz and M. M. Amin, "EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence," Diagnostic Pathology, vol. 7, no. 1, p. 14, 2012.
10. S. Sharma, M. C. Sharma, and C. Sarkar, "Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis," Histopathology, vol. 46, no. 5, pp. 481-489, 2005.
11. H. Kumamoto, K. Yamauchi, M. Yoshida, and K. Ooya, " Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors ofmetalloproteinases (TIMPs) in ameloblastomas," Journal of Oral Pathology and Medicine, vol. 32, no. 2, pp. 114-120, 2003.
12. J. J. Pinheiro, V. M. Freitas, A. I. Moretti, A. G. Jorge, and R. G. Jaeger, "Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity," Histopathology, vol. 45, no. 1, pp. 65-72, 2004.
13. A. S. Siqueira, M. R. Carvalho, A. C. Monteiro, V. M. Freitas, R. G. Jaeger, and J. J. Pinheiro, "Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour," Histopathology, vol. 57, no. 1, pp. 128-137, 2010.
14. S. Seifi, S. Shafaie, and S. Ghadiri, "Microvessel density in follicular cysts, keratocystic odontogenic tumours and ameloblastomas," Asian Pacific Journal of Cancer Prevention, vol. 12, no. 2, pp. 351-356, 2011.
15. A. Florescu, C. Simionescu, R. Ciurea, and A. Pitru, "P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas," Romanian Journal of Morphology and Embryology, vol. 53, no. 1, pp. 105-109, 2012.
16. N.Weidner, J. P. Semple,W. R.Welch, and J. Folkman, "Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma,"The New England Journal of Medicine, vol. 324, no. 1, pp. 1-8, 1991.
17. H.-J. Yoon, B. C. Jo, W. J. Shin et al., "Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 112, no. 6, pp. 767-776, 2011.
18. V. J. Paikkatt, S. Sreedharan, and V. P. Kannan, "Unicystic ameloblastoma of themaxilla: a case report," Journal of Indian Society of Pedodontics and PreventiveDentistry, vol. 25,no. 2, pp. 106-110, 2007.
19. C. C. Black, R. R. Addante, and C. A. Mohila, "Intraosseous ameloblastoma," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 110, no. 5, pp. 585-592, 2010.
20. S.Meer, J. S. Galpin,M. Altini, H. Coleman, and H. Ali, "Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 95, no. 2, pp. 213-221, 2003.
21. C. Rizzardi, P. Leocata, L. Ventura et al., "Apoptosis-related factors (TRAIL, DR4, DR5, DcRl, DcR2, apoptotic cells) and proliferative activity in ameloblastomas," Anticancer Research, vol. 29, no. 4, pp. 1137-1142, 2009.
22. T.-J. Li, R. M. Browne, and J. B. Matthews, "Expression of proliferating cell nuclear antigen (PCNA) andKi-67 in unicystic ameloblastoma," Histopathology, vol. 26, no. 3, pp. 219-228, 1995.
23. R. Bologna-Molina, A. Mosqueda-Taylor, N. Molina-Frechero, A.D.Mori-Estevez, and G. Sánchez-Acuña, "Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors," Medicina Oral, Patología Oral y Cirugía Bucal, vol. 18, no. 2, pp. e174-e179, 2013.
24. M. Alaeddini, S. Salah, F. Dehghan, N. Eshghyar, and S. Etemad-Moghadam, "Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ameloblastomas," Oral Diseases, vol. 15, no. 6, pp. 422-427, 2009.
25. L. J. Jiang, C.K. Shao, D. He,W.G. Li, X. Z. Wu, and D.-Z. Cai, "Correlations of extrocellularmatrixmetalloproteinase inducer and microvessel density to invasiveness of ameloblastoma," Ai Zheng, vol. 27, no. 12, pp. 1263-1266, 2008.
26. A. H. Hande, A. R. Gadbail, A. M. Sonone, M. S. Chaudhary, V. Wadhwan, and A. Nikam, "Comparative analysis of tumour angiogenesis in solid multicystic and unicystic ameloblastoma by using CD 105 (endoglin)," Archives of Oral Biology, vol. 56, no. 12, pp. 1635-1640, 2011.
27. M. Björklund and E. Koivunen, "Gelatinase-mediated migration and invasion of cancer cells," Biochimica et Biophysica Acta, vol. 1755, no. 1, pp. 37-69, 2005.
28. G. Klein, E. Vellenga, M. W. Fraaije, W. A. Kamps, and E. S. de Bont, "The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. leukemia," Critical Reviews in Oncology/Hematology, vol. 50, no. 2, pp. 87-100, 2004.
29. H. D. Foda and S. Zucker, "Matrixmetalloproteinases in cancer invasion, metastasis and angiogenesis," Drug Discovery Today, vol. 6, no. 9, pp. 478-482, 2001.
30. A. C. Henriques, M. G. Vasconcelos, H. C. Galvão, L. B. De Souza, and R. D. A. Freitas, "Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors," Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 112, no. 4, pp. 468-475, 2011.